Nifty 17401.65 (1.37%)
Sensex 58461.29 (1.35%)
Nifty Bank 36508.25 (0.39%)
Nifty IT 36157.85 (2.06%)
Nifty Financial Services 17982.9 (1.26%)
Adani Ports 739.10 (4.40%)
Asian Paints 3180.60 (1.35%)
Axis Bank 676.10 (-0.52%)
B P C L 378.85 (2.74%)
Bajaj Auto 3328.40 (2.43%)
Bajaj Finance 7180.50 (2.01%)
Bajaj Finserv 17758.15 (2.16%)
Bharti Airtel 732.55 (1.43%)
Britannia Inds. 3578.50 (1.22%)
Cipla 921.25 (-0.74%)
Coal India 159.30 (2.41%)
Divis Lab. 4777.30 (0.53%)
Dr Reddys Labs 4662.75 (1.22%)
Eicher Motors 2451.55 (0.54%)
Grasim Inds 1723.85 (2.63%)
H D F C 2807.80 (3.85%)
HCL Technologies 1184.70 (2.42%)
HDFC Bank 1525.75 (1.40%)
HDFC Life Insur. 705.30 (1.65%)
Hero Motocorp 2472.70 (1.00%)
Hind. Unilever 2383.30 (1.64%)
Hindalco Inds. 432.10 (1.69%)
I O C L 120.65 (2.51%)
ICICI Bank 722.40 (-0.73%)
IndusInd Bank 945.55 (1.27%)
Infosys 1748.25 (1.94%)
ITC 225.45 (1.60%)
JSW Steel 646.75 (1.50%)
Kotak Mah. Bank 1964.25 (0.56%)
Larsen & Toubro 1789.20 (0.18%)
M & M 849.55 (1.78%)
Maruti Suzuki 7324.95 (0.71%)
Nestle India 19503.20 (0.54%)
NTPC 128.70 (0.78%)
O N G C 144.00 (1.23%)
Power Grid Corpn 214.50 (3.52%)
Reliance Industr 2482.85 (0.64%)
SBI Life Insuran 1188.05 (1.99%)
Shree Cement 26289.80 (0.76%)
St Bk of India 477.00 (0.36%)
Sun Pharma.Inds. 766.25 (2.80%)
Tata Consumer 773.25 (0.06%)
Tata Motors 479.10 (0.81%)
Tata Steel 1112.40 (2.76%)
TCS 3642.90 (1.82%)
Tech Mahindra 1629.65 (2.65%)
Titan Company 2386.50 (1.11%)
UltraTech Cem. 7323.20 (0.01%)
UPL 698.20 (1.12%)
Wipro 646.80 (1.89%)
INFY

Unichem Laboratories Ltd.

₹223.95
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Unichem Labs.

  • Master Rating:
  • Unichem Laboratories has an operating revenue of Rs. 1,188.98 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 4% needs improvement, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 6 which is a POOR score indicating inconsistency in earnings, a RS Rating of 3 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 146 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Unichem Laboratories Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Unichem Laboratories Ltd Synopsis

NSE-Medical-Diversified

Unichem Labs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1123.97 Cr. and Equity Capital is Rs. 14.08 Cr. for the Year ended 31/03/2021. Unichem Laboratories Ltd. is a Public Limited Listed company incorporated on 22/08/1962 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1962PLC012451 and registration number is 012451.
  • Market Cap

    INR 1,576.74 Cr

  • Sales

    INR 990.04 Cr

  • Shares in Float

    3.45 Cr

  • No of Funds

    34 K

  • Yield

    1.79%

  • Book Value

    0.58

  • U/D Vol Ratio

    0.9

  • LTDebt/Equity

    %

  • Alpha

    -0.07

  • Beta

    0.39

Unichem Laboratories Ltd Ownership
Unichem Laboratories Ltd Management

Unichem Laboratories Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 2697.33472647.18382731.93412761.6661130.728
Fixed Assets Annual Cr 1417.49311159.3691879.0692790.3722715.2151
Total Non Current Assets Annual Cr 1813.69071520.41971177.124895.5591815.6916
Total Current Assets Annual Cr 1305.36661504.71481853.09972207.3579687.2488
Total Assets Annual Cr 3119.05733025.13453030.22373102.9171502.9404
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 383.1114375.9882388.1496392.6334124.4246
ROE Annual % 2-2.120.3292.579.18
ROCE Annual % 2.43-2.33-0.75-4.21-7.51
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 12.70.944.21-10.95-8.82

Unichem Laboratories Ltd Technicals

EMA & SMA

CURRENT PRICE

223.95 (5.96)

    • Bullish Moving Averages 9
    • Bearish Moving Averages 7

EMA

  • 20 Day

    218.53

  • 50 Day

    237.33

  • 100 Day

    260.56

  • 200 Day

    298.13

Unichem Laboratories Ltd Resistance and support

213.64 PIVOT

  • First Resistance

    218.57

  • Second Resistance

    225.79

  • Third Resistance

    230.72

  • First Support

    206.42

  • Second Support

    201.49

  • Third Support

    194.27

  • RSI

    50.59

  • MFI

    54.47

  • MACD

    -6.95

  • MACD signal line

    -10.16

Unichem Laboratories Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 171,448 7,012,223 40.9%
Week 438,822 11,729,717 26.73%
1 Month 178,274 6,072,018 34.06%
6 Month 102,415 4,018,775 39.24%

Unichem Laboratories Ltd Price change analysis

-3.65

Over 1 month

Low High
197.5 246.7

-65

Over 3 month

Low High
197.5 292.85

-106.15

Over 6 months

Low High
197.5 345

-29.45

Over Year

Low High
197.5 375

Similar Stocks

News

UNICHEM LABORATORIES LTD. - 506690 - ANDA Approval For Aripi

ANDA approval for Aripiprazole Tablets Read More

Unichem Laboratories climbs 19% after ICRA reaffirms long-te

The share touched its 52-week high of Rs 374.90 and 52-week low of Rs 197.50 on May 21, 2021 and November 22, 2021, respectively. Read More

Unichem Laboratories Ltd - 506690 - Announcement under Regul

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. ICRA Rating - assigned credit ra Read More

Unichem Laboratories Ltd - 506690 - Announcement under Regul

Financial Results for the second quarter and six months ended September 30, 2021 published in newspapers on November 3, 2021. Read More

UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Outcome f

Unaudited financial results (Standalone and Consolidated) for the second quarter and six months ended 30.9.2021 Read More

Blogs

FAQs